Durable cytogenetic and molecular responses were observed irrespective of baseline mutation status, and included patients with compound mutations. No single or compound mutation was identified that consistently conferred primary and/or secondary resistance to ponatinib in CP-CML patients.
Expansion of a new business enterprise too rapidly causes many new companies to absolutely fail. It is all about business evolution.
Read or ask Dr. Cortez.
Meant for twenty somethings to day trade
You guys are strange. Your taking a drug for constipation, and your complaining about a little diarrhea. Make sense!! Do you have any idea what a relief that would be?? Ask any one that has had this condition. I have.
Looking good, plus they will be in China soon..